Battle-Lines Built Up On Biologic Substitution In Germany

 
• By Aidan Fry

German legislators are faced with entrenched positions on pharmacy-level switching of biologic drugs as they consider draft legislation. Industry is united in opposing the proposal.

Warriors
Lines are being drawn up by stakeholders on either side of the debate around pharmacy-level substitution of biological drugs in Germany • Source: Shutterstock

More from Biosimilars

More from Products